imatinib mesylate has been researched along with Hypertension, Malignant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graciano, ML; Mitchell, KD | 1 |
1 other study(ies) available for imatinib mesylate and Hypertension, Malignant
| Article | Year |
|---|---|
Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Benzamides; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Imatinib Mesylate; Indoles; Kidney; Male; Piperazines; Pyrimidines; Rats; Rats, Transgenic; Receptors, Platelet-Derived Growth Factor; Renin | 2012 |